HRMY Insider Trading

Insider Ownership Percentage: 23.60%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $3,709,632.36

Harmony Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Harmony Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$40M-$20M$0$20M$40MTotal Insider BuyingTotal Insider Selling

Harmony Biosciences Share Price & Price History

Current Price: $30.32
Price Change: Price Increase of +0.46 (1.54%)
As of 05/2/2025 05:00 PM ET

This chart shows the closing price history over time for HRMY up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JunJulAugSepOctNovDecJanFebMarApr$30.32Closing price on 05/03/25:

SEC Filings (Institutional Ownership Changes) for Harmony Biosciences (NASDAQ:HRMY)

86.23% of Harmony Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at HRMY by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$15Mbought$2.70MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$200M-$100M$0$100M$200MTotal InflowsTotal Outflows
Harmony Biosciences logo
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.
Read More on Harmony Biosciences

Today's Range

Now: $30.32
Low: $29.72
High: $30.61

50 Day Range

MA: $31.41
Low: $27.94
High: $35.28

52 Week Range

Now: $30.32
Low: $26.47
High: $41.61

Volume

857,912 shs

Average Volume

574,597 shs

Market Capitalization

$1.74 billion

P/E Ratio

14.37

Dividend Yield

N/A

Beta

0.82

Who are the company insiders with the largest holdings of Harmony Biosciences?

Harmony Biosciences' top insider investors include:
  1. Jeffrey Dierks (Insider)
  2. Jeffrey M Dayno (CEO)
  3. Sandip Kapadia (CFO)
Learn More about top insider investors at Harmony Biosciences.

Who are the major institutional investors of Harmony Biosciences?

Harmony Biosciences' top institutional shareholders include:
  1. Massachusetts Financial Services Co. MA — 1.31%
  2. Bank of New York Mellon Corp — 0.46%
  3. Principal Financial Group Inc. — 0.37%
  4. Victory Capital Management Inc. — 0.37%
  5. Bridge City Capital LLC — 0.28%
  6. Rhumbline Advisers — 0.19%
Learn More about top institutional investors of Harmony Biosciences stock.

Which institutional investors are selling Harmony Biosciences stock?

Within the previous quarter, HRMY stock was sold by these institutional investors:
  1. Massachusetts Financial Services Co. MA
  2. Bank of New York Mellon Corp
  3. Janney Montgomery Scott LLC
  4. Illinois Municipal Retirement Fund
  5. Avanza Fonder AB
  6. Summit Global Investments
  7. China Universal Asset Management Co. Ltd.
  8. State of Alaska Department of Revenue
Within the last year, company insiders that have sold Harmony Biosciences company stock include:
  1. Jeffrey Dierks (Insider)
  2. Jeffrey M Dayno (CEO)
  3. Sandip Kapadia (CFO)
Learn More investors selling Harmony Biosciences stock.

Which institutional investors are buying Harmony Biosciences stock?

Within the last quarter, HRMY stock was acquired by institutional investors including:
  1. GAMMA Investing LLC
  2. CX Institutional
  3. Edgestream Partners L.P.
  4. Victory Capital Management Inc.
  5. Bridge City Capital LLC
  6. Exchange Traded Concepts LLC
  7. Moloney Securities Asset Management LLC
  8. SG Americas Securities LLC